Longyuan Gains 'Nuclear' Momentum: National Nuclear Medicine Demonstration Base Settles in Wuwei...

Longyuan Gains 'Nuclear' Momentum: National Nuclear Medicine Demonstration Base Settles in Wuwei, Charting a New Blueprint for Western Health Development in the 15th Five-Year Plan

On October 31, the Kick-off Meeting (19th Session) of the Promotion and Demonstration Project for Nuclear Medicine Diagnosis and Treatment—led by the Nuclear Medicine Branch of the Chinese Medical Association—was ceremoniously held at Wuwei Cancer Hospital in Gansu Province.

After rigorous selection, this national demonstration projecthas officially settled in the hospital. This milestone not only marks the hospital’s successful entry into the ranks of national demonstration bases for nuclear medicine diagnosis and treatmentbut also ushers its nuclear medicine discipline into a new era of standardized, regulated, and high-quality development. More importantly, it will deliver better, more precise, and more accessible medical servicesto the people of Wuwei and the broader Northwest China.

The event served as both a comprehensive review of the hospital’s five-year development achievementsand a forward-looking launchpad: taking the 15th Five-Year Planas a new starting point, it unveiled the hospital’s strategic layout of cutting-edge oncology diagnosis and treatment technologies. It is now forging ahead at full speed toward its ambitious goal: to become “the National Regional Medical Center for Heavy Ion Radiotherapy with the Most Comprehensive Tumor Radiotherapy Modalities in Western China”.

As a key benchmark platform for heavy ion tumor treatment in China, Wuwei Cancer Hospital (Gansu Province)has long been deeply engaged in oncology diagnosis and treatment. It has consistently leveraged integrated multidisciplinary developmentas a driving force, sparing no effort to advance upgrades in precision medicine technology and service innovation.

Nuclear medicine—serving as a core supporting discipline for precision medicine—has emerged as a distinctive branded disciplineunder the hospital’s prioritized cultivation. This achievement is underpinned by its solid clinical experience, state-of-the-art hardware facilities, and a high-caliber, specialized talent pipeline.

The hospital’s successful designation as a National Demonstration Base for Nuclear Medicine Diagnosis and Treatmentnot only validates its hard strength in discipline construction but also reflects high recognition from the Nuclear Medicine Branch of the Chinese Medical Associationfor its work in clinical practice, talent training, and technology dissemination. It sets a referable and exemplary benchmarkfor grassroots nuclear medicine development across Western China and beyond.

The launch of this demonstration base project not only summarizes the hospital’s five-year progress but also marks a critical starting point for its journey into the 15th Five-Year Planera.

It is understood that during the 15th Five-Year Plan period, the Wuwei Heavy Ion Centerwill focus on cutting-edge tumor treatment innovation. Key priorities include:

•Deploying frontier technologies such as light ion therapy, boron neutron capture therapy (BNCT), alpha isotope targeted therapy, and cell therapy;

•Advancing core tasks like constructing heavy ion science and innovation platforms, attracting and cultivating high-level talents, incubating medical equipment, and issuing heavy ion industry standards.

The center aims to become a national cradle for heavy ion talent, an academic hub, and a research stronghold. It is committed to building—at an early date—the “National Regional Medical Center for Heavy Ion Radiotherapy with the Most Comprehensive Tumor Radiotherapy Modalities in Western China”, and contributing a stronger “Wuwei Strength” to advancing Healthy Chinain the western region.

Professor Nie Peng, Vice President of Wuwei Cancer Hospital (Gansu Province), presided over the event.

Professor Wang Jing, Chairman of the Nuclear Medicine Branch of the Chinese Medical Association, delivered speeches.

Professor Ye Yancheng, President of Wuwei Cancer Hospital (Gansu Province), delivered speeches.

At the kick-off meeting, top industry experts converged to share in this momentous occasion. Gathered on site to witness this significant moment were authoritative nuclear medicine specialists from both within and outside Gansu Province—including: Professor Wang Jing, Director of the Nuclear Medicine Branch of the Chinese Medical Association; Professor Wei Hua, Deputy Head of the Youth Group of the Nuclear Medicine Branch and a physician from the First Hospital of Shanxi Medical University; Professor Gao Rui, Deputy Head of the Youth Committee of the Nuclear Medicine Physicians Branch of the Chinese Medical Doctor Association and a faculty member at Xi’an Jiaotong University; Professor Zhang Chunyin from the Affiliated Hospital of Southwest Medical University; Professor Liu Chun, Director of the Nuclear Medicine Branch of the Gansu Provincial Medical Association; and Professor Chen Ming, Director of the Quality Control Center.

The meeting was chaired by Professor Nie Peng, Vice President of Wuwei Cancer Hospital. Professor Wang Jing and Professor Ye Yancheng, President of the hospital, each delivered speeches.

Witnessed by all attendees, Professor Wang Jing and President Ye jointly signed the cooperation agreement, while participating experts together lit the launch device—officially marking the demonstration base project’s entry into its substantive construction phase.

President Ye Yancheng stated that the hospital will center its efforts on the demonstration base’s development: pooling high-quality resources to refine its nuclear medicine diagnosis and treatment system, focusing on precision nuclear medicine for major conditions like tumors, cardiovascular diseases, and neurological disorders, and striving to build a regional model benchmarkdefined by "integrated diagnosis and treatment, standardized management, and homogeneous technology". He emphasized that this initiative will enable cutting-edge nuclear medicine technologies to better serve the health needs of people across western China.

During the academic exchange segment, Professor Wang Jing delivered a keynote speech titled "Current Status and Prospects of Nuclear Medicine in China". She systematically reviewed frontier trends and development directions in both global and domestic nuclear medicine, providing high-level strategic guidancefor the demonstration base’s construction.

Professor Gao Rui and Professor Zhang Chunyin followed with in-depth presentations: one focusing on "Clinical Application and Experience of 90Y-SIRT in Hepatocellular Carcinoma"and the other on "Current Status and Progress of Precision Targeted Radionuclide Diagnosis-Treatment Integration for Prostate Cancer". Grounded in the actual development of Wuwei Cancer Hospital’s Nuclear Medicine Department, they proposed highly targeted innovations—including new ideas for clinical application and pathways for technical upgrading—that broadened horizons and clarified directions for the discipline’s high-quality growth.

Professor Wang Jing of Xijing Hospital delivered a lecture.

Professor Gao Rui of The First Affiliated Hospital of Xi'an Jiaotong University delivered a lecture.

Professor Zhang Chunyin of The Affiliated Hospital of Southwest Medical University delivered a lecture.

Professor An Jianping of the 940 Hospital of the Joint Logistics Support Force of the PLA and Professor Liu Chun of The First Hospital of Lanzhou University co-chaired the session.

Professor Chen Ming of The First Hospital of Lanzhou University and Professor Wang Haijun of Gansu Provincial People's Hospital co-chaired the session.

Professor Wang Zhimin of Gansu Provincial People's Hospital and Professor Zeng Xianwu of Gansu Cancer Hospital co-chaired the session.

After the meeting, attending experts conducted an on-site inspection and research tour of the hospital’s Nuclear Medicine Department. They successively visited core areas including the PET-CT examination room, radionuclide therapy ward, and in vitro analysis laboratory—carefully evaluating the department’s hardware infrastructure, diagnostic/treatment process standardization, and quality control management. They also listened attentively to briefings from technical leads on equipment operation, clinical application, and research progress.

Witnessing the department’s advanced diagnostic tools, rigorous operational protocols, and comprehensive service system, the experts spoke highly of its capabilities—noting that the Nuclear Medicine Department had already established strong demonstration and leadership in technology application and operational management. Drawing on clinical needs, they further provided valuable guidance on optimizing workflows and enhancing technical proficiency.

The establishment of this National Demonstration Base for Nuclear Medicine Diagnosis and Treatmentmarks the official transition of Wuwei Cancer Hospital’s (Gansu Province) Nuclear Medicine Discipline into a new phase of high-quality development.

Looking ahead, the hospital will build on this demonstration base to:

•Continuously integrate top-tier resources;

•Explore innovative service models;

•While enhancing its diagnostic/treatment capabilities and research proficiency, fully leverage its demonstrative and leading roleto advance the popularization of nuclear medicine technology and standardized development across the region.

•This endeavor will inject strong momentum into safeguarding public healthand furthering the Healthy Chinamission.

Preliminary Review: Zhang Jie  

Final Review: Ma Shuqian